Intra-Cellular Therapies, Inc.
ITCI · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17 | -$26 | -$16 | -$15 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16 | $17 | $16 | $14 |
| Change in WC | -$10 | -$16 | $2 | -$31 |
| Other Non-Cash | -$3 | -$2 | $25 | $29 |
| Operating Cash Flow | -$13 | -$27 | $1 | -$34 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$258 | -$313 | -$89 | -$81 |
| Inv. Sales/Matur. | $107 | $104 | $96 | $97 |
| Other Inv. Act. | $0 | $0 | $8 | $16 |
| Investing Cash Flow | -$150 | -$209 | $8 | $16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$12 | $545 | $10 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | $7 | $545 | $10 |
| Financing Cash Flow | $6 | $7 | $545 | $10 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$157 | -$229 | $553 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $466 | $695 | $142 | $150 |
| End Cash | $309 | $466 | $695 | $142 |
| Free Cash Flow | -$13 | -$27 | $0 | -$34 |